Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics
Lauren Forchette, William Sebastian, Tuoen Liu
Current Medical Science (2021) Vol. 41, Iss. 6, pp. 1037-1051
Open Access | Times Cited: 224

Showing 1-25 of 224 citing articles:

Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy
Yi-Zhou Jiang, Limor Rubin, Tangming Peng, et al.
International Journal of Biological Sciences (2021) Vol. 18, Iss. 2, pp. 459-472
Open Access | Times Cited: 107
Insights into the Structure of Comirnaty Covid-19 Vaccine: A Theory on Soft, Partially Bilayer-Covered Nanoparticles with Hydrogen Bond-Stabilized mRNA–Lipid Complexes
János Szebeni, Bálint Kiss, Tamás Bozó, et al.
ACS Nano (2023) Vol. 17, Iss. 14, pp. 13147-13157
Open Access | Times Cited: 41
A focused review on technologies, mechanisms, safety, and efficacy of available COVID-19 vaccines
Parisa Ghasemiyeh, Soliman Mohammadi‐Samani, Negar Firouzabadi, et al.
International Immunopharmacology (2021) Vol. 100, pp. 108162-108162
Open Access | Times Cited: 86
A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant
Mengxin Zhang, Ying Liang, Dongsheng Yu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 2, pp. 889-900
Open Access | Times Cited: 60
Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination
Salvatore Pepe, Ann Gregory, A. Robert Denniss
Heart Lung and Circulation (2021) Vol. 30, Iss. 10, pp. 1425-1429
Open Access | Times Cited: 55
Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences
Reem Hoteit, Hadi M. Yassine
Vaccines (2022) Vol. 10, Iss. 6, pp. 919-919
Open Access | Times Cited: 38
Neurological toll of COVID-19
Shivam Bhola, Jhillika Trisal, Vikram Thakur, et al.
Neurological Sciences (2022) Vol. 43, Iss. 4, pp. 2171-2186
Open Access | Times Cited: 37
Two pan-SARS-CoV-2 nanobodies and their multivalent derivatives effectively prevent Omicron infections in mice
Honghui Liu, Lili Wu, Bo Liu, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 2, pp. 100918-100918
Open Access | Times Cited: 31
Immune Response and Molecular Mechanisms of Cardiovascular Adverse Effects of Spike Proteins from SARS-CoV-2 and mRNA Vaccines
Paolo Bellavite, Alessandra Ferraresi, Ciro Isidoro
Biomedicines (2023) Vol. 11, Iss. 2, pp. 451-451
Open Access | Times Cited: 29
Efficacy and safety of SIM0417 (SSD8432) plus ritonavir for COVID-19 treatment: a randomised, double-blind, placebo-controlled, phase 1b trial
Fuxiang Wang, Wen Xiao, Yimin Tang, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 38, pp. 100835-100835
Open Access | Times Cited: 24
The Role of Cyclodextrins in COVID-19 Therapy—A Literature Review
Beatriz C. Almeida, Cátia Domingues, Filipa Mascarenhas‐Melo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2974-2974
Open Access | Times Cited: 22
The importance of using WHO International Standards to harmonise SARS-CoV-2 serological assays
Heidi Hempel, Mark Page, Troy J. Kemp, et al.
The Lancet Microbe (2024) Vol. 5, Iss. 3, pp. e301-e305
Open Access | Times Cited: 8
Sustainable materials and COVID-19 detection biosensor: A brief review
Sora Yasri, Viroj Wiwanitkit
Sensors International (2022) Vol. 3, pp. 100171-100171
Open Access | Times Cited: 31
Computational Investigations for Identification of Bioactive Molecules from Baccaurea ramiflora and Bergenia ciliata as Inhibitors of SARS-CoV-2 Mpro
James H. Zothantluanga, Mohnad Abdalla, Mithun Rudrapal, et al.
Polycyclic aromatic compounds (2022) Vol. 43, Iss. 3, pp. 2459-2487
Closed Access | Times Cited: 27
Immunological investigation of a multiepitope peptide vaccine candidate based on main proteins of SARS-CoV-2 pathogen
Niloofar Khairkhah, Azam Bolhassani, Elnaz Agi, et al.
PLoS ONE (2022) Vol. 17, Iss. 6, pp. e0268251-e0268251
Open Access | Times Cited: 27
The Prognostic Value of Pentraxin-3 in COVID-19 Patients: A Systematic Review and Meta-Analysis of Mortality Incidence
Anna Paola Capra, Alessio Ardizzone, Giuseppe Pantò, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3537-3537
Open Access | Times Cited: 19
COVID-19 Affects Serum Brain-Derived Neurotrophic Factor and Neurofilament Light Chain in Aged Men: Implications for Morbidity and Mortality
Carla Petrella, Maria Antonella Zingaropoli, Flavio Maria Ceci, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 655-655
Open Access | Times Cited: 19
Design, synthesis, and computational studies of novel imidazo[1,2-a]pyrimidine derivatives as potential dual inhibitors of hACE2 and spike protein for blocking SARS-CoV-2 cell entry
Mohamed Azzouzi, Zainab El Ouafi, Omar Azougagh, et al.
Journal of Molecular Structure (2023) Vol. 1285, pp. 135525-135525
Open Access | Times Cited: 19
Emergence of mRNA vaccines in the management of cancer
Mohamad Irfan Mohamad Razif, Nabilah Nizar, Nur Hannah Zainal Abidin, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 629-642
Open Access | Times Cited: 17
Efficacy and safety of paxlovid (nirmatrelvir/ritonavir) in the treatment of COVID‐19: An updated meta‐analysis and trial sequential analysis
Haokun Tian, Changsen Yang, Tiangang Song, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 5
Closed Access | Times Cited: 17
Challenges Faced by Nursing Professionals in COVID-19 Pandemic
Shipra Daniel, Abdulaziz Alzahrani, Waleed Hassan Almalki, et al.
Springer eBooks (2024), pp. 21-34
Closed Access | Times Cited: 6
SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines
Xi Li, Ze Mi, Zhenguo Liu, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 5
A review of RNA nanoparticles for drug/gene/protein delivery in advanced therapies: Current state and future prospects
Pegah Vosoughi, Seyed Morteza Naghib, Babak Mikaeeli Kangarshahi, et al.
International Journal of Biological Macromolecules (2025) Vol. 295, pp. 139532-139532
Closed Access
COVID-19 Symptoms Only Minutely Influenced by Genes Among Children in a Nationwide Twin Cohort
Anna M. Hedman, Camilla Palm, Patrik K. E. Magnusson, et al.
The Pediatric Infectious Disease Journal (2025)
Closed Access
Atomic Insights into pH-Dependent and Water Permeation of mRNA-Lipid Nanoparticles
Shouhua Feng, Guang‐Wen Chu, Hui Li, et al.
Molecular Pharmaceutics (2025)
Closed Access
Page 1 - Next Page

Scroll to top